USPTO trademark

REPTYROS

Under examinationUSPTOWord markClass 5

"REPTYROS" is a word mark owned by Turning Point Therapeutics, Inc., filed at the USPTO on September 3, 2026. It is under examination and covers class 5 (Pharmaceuticals).

Get this data via the API
Official USPTO record
REPTYROS trademark as filed
As filed with the USPTO
Status
Under examination
Since September 3, 2026
Filed
September 3, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50089333
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns REPTYROS

The owner and representative on file with the office.

Owner

Turning Point Therapeutics, Inc.

Princeton, United States

Representative

Marilyn F. Kelly

Bristol-Myers Squibb Company

Goods and services

What the mark covers

The products and services REPTYROS is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About REPTYROS

Who owns the trademark "REPTYROS"?

The USPTO trademark "REPTYROS" (application 50089333) is owned by Turning Point Therapeutics, Inc.

What is the status of "REPTYROS"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull REPTYROS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a06c87-4581-71d8-bfee-c487d79bc99b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a06c87-4581-71d8-bfee-c487d79bc99b",
  "object": "trademark",
  "mark_text": "REPTYROS",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50089333",
  "filing_date": "2026-09-03",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Turning Point Therapeutics, Inc.",
      "entity_id": null
    }
  ]
}